HUB Organoids as a New Diagnostic Platform to Improve Cancer Patient Treatment

Time: 2:20 pm
day: Day One


  • How to generate unique clinically relevant patient-derived models using HUB Organoid Technology
  • HUB Organoids capture tumour heterogeneity and preserve tumour genetic make-up and pathology
  • Published clinical data have shown that HUB Organoids mimic patient response
  • The use of an organoid-based platform for drug screening, patient stratification, and personalised medicine approaches